Suchergebnisse - "van Halteren, H"

PubPharm (37)

1

A conceptual framework for cautious escalation of anticancer treatment : How to optimize overall benefit and obviate the need for de-escalation trials

enthalten in: Cancer treatment reviews | 2024

von Pourmir, I. | Van Halteren, H. | Elaidi, R. | +4

2

Reporting and analysis of immunotherapy trials adverse events : what is going wrong, how to do better?

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Pourmir, I. | Nebbache, R. | Champiat, S. | +23

3

Twelve ESMO Congress 2022 breakthroughs : practicing oncologists' perceptions and potential application on presented data

enthalten in: ESMO open | 2023

von van Halteren, H. | Bennouna, J. | Brasiuniene, B. | +10

4

11 ESMO 2021 breakthroughs : practicing oncologist's perceptions on data presentation

enthalten in: ESMO open | 2022

von van Halteren, H. | Tan, A. | Pellegrino, B. | +5

5

Managing cancer patients during the COVID-19 pandemic : an ESMO multidisciplinary expert consensus

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Curigliano, G. | Banerjee, S. | Cervantes, A. | +76

6

Reply to 'Statistical controversies in clinical research : end points other than survival are vital for regulatory approval of anticancer agents' by Saad and Buyse

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2016

von van Halteren, H.

CommentOn: Ann Oncol. 2016 Mar;27(3):373-8. - PMID 26578738

7

Reply to 'Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents' by Saad and Buyse

enthalten in: Annals of oncology | 2016

von van Halteren, H.

8

Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer

enthalten in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology | 2015

von van Erning, F. | Rutten, H. | van den Berg, H. | +2

9

De reanimatieparadox bij patiënten met kanker

enthalten in: Nederlands tijdschrift voor geneeskunde | 2014

von Van Halteren, H.

10

Naar Engels voorbeeld - Nieuwe oncologiemedicijnen worden in Nederland betrekkelijk vlotjes geregistreerd. Dat lijkt goed nieuws, maar de kosten rijzen de pan uit. Hoog tijd om de teugels wat aan te halen. Is het Engelse model niet wat voor Nederland?

enthalten in: Medisch contact | 2009

von van Halteren, H. | Kerkhofs, L. | van der Meer, Y.